Format

Send to:

Choose Destination
See comment in PubMed Commons below
Korean J Ophthalmol. 2013 Feb;27(1):34-8. doi: 10.3341/kjo.2013.27.1.34. Epub 2013 Jan 9.

Long-term results of deep sclerectomy with small collagen implant in Korean.

Author information

  • 1Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea.

Abstract

PURPOSE:

To describe the long-term results of deep sclerectomy with collagen implant (DSCI) with or without adjuvant mitomycin C in Korean patients with primary or secondary open-angle glaucoma (OAG).

METHODS:

This retrospective review was comprised of 65 Korean patients who received DSCI with or without adjuvant mitomycin C due to primary or secondary OAG. Patients were followed for 72 months after surgery. Complete success was defined as intraocular pressure (IOP) <21 mmHg without medication and qualified success was defined as IOP <21 mmHg with or without medication.

RESULTS:

Mean postoperative follow-up period was 53.0 ± 16.2 months. Mean IOP was 30.5 ± 11.7 mmHg preoperatively, 8.4 ± 4.3 mmHg at postoperative day one and 13.4 ± 3.8 mmHg 60 months after surgery. The mean number of glaucoma medications was decreased from 3.6 ± 1.1 to 1.6 ± 1.3 at 60 months after the operation. Complete and qualified success rates were 36.7% and 79.6% at postoperative 60 months, respectively (Kaplan-Meier survival curve). No shallow or flat anterior chamber, endophthalmitis, or surgery-induced significant cataract was observed.

CONCLUSIONS:

The results of DSCI in Korean patients presented here seem reasonably excellent with qualified success rates of over 70% at six years with negligible complications.

KEYWORDS:

Deep sclerectomy; Koreans; Open-angle glaucoma; Small collagen implant

PMID:
23372377
[PubMed - indexed for MEDLINE]
PMCID:
PMC3550309
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for KoreaMed Icon for PubMed Central
    Loading ...
    Write to the Help Desk